Enovis (ENOV) Operating Income Growth (5y) (2015 - 2026)
Enovis (ENOV) Operating Income Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.63 Bn | 67.18 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.43 Bn | 44.76 Bn | 1.29 Bn |
| 6 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.14 Bn | 25.85 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.32 Bn | - |
| 9 | Koninklijke Philips | 24.25 Bn | 21.12 Bn | 2.07 Bn |
| 10 | Enovis | 1.59 Bn | 1.56 Bn | 365.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -36.10% |
| Dec 31, 2025 | -24.18% |
| Oct 3, 2025 | -61.59% |
| Jul 4, 2025 | -27.83% |
| Apr 4, 2025 | -24.56% |
| Dec 31, 2024 | -55.99% |
| Sep 27, 2024 | -19.80% |
| Jun 28, 2024 | -25.11% |
| Mar 29, 2024 | -76.25% |
| Dec 31, 2023 | -17.24% |
| Sep 29, 2023 | -20.91% |
| Jun 30, 2023 | -18.32% |
| Mar 31, 2023 | -19.15% |
| Dec 31, 2022 | 16.52% |
| Sep 30, 2022 | -17.50% |
| Jul 1, 2022 | -39.78% |
| Apr 1, 2022 | -20.19% |
| Dec 31, 2021 | -18.19% |
| Oct 1, 2021 | -17.86% |
| Jul 2, 2021 | -16.45% |